Heart Failure, Nutrient Depletion, and Medication Effects
Heart failure occurs when the heart is unable to pump enough blood to meet the body’s needs. It typically develops gradually as the heart muscle weakens or becomes less able to fill properly. In some cases, the heart cannot fill with enough blood; in others, it lacks the strength to pump blood effectively to the rest of the body.
Heart failure is a common condition. According to the National Heart, Lung, and Blood Institute, millions of people in the United States are affected, with hundreds of thousands of new cases diagnosed each year.
Heart failure may involve the left side of the heart, the right side, or both. Right-sided heart failure occurs when the heart cannot pump blood efficiently to the lungs and may result in fluid accumulation in the legs, abdomen, liver, or neck veins. Left-sided heart failure occurs when the heart cannot adequately supply oxygen-rich blood to the body and often causes fatigue and shortness of breath. When both sides are involved, symptoms may be more pronounced.
Common contributing factors to heart failure include diabetes, high blood pressure, and coronary artery disease. Medication effects may also play a role in some patients, particularly through nutrient depletion.
Statins, Coenzyme Q10, and Cardiac Energy
Statin medications lower cholesterol by inhibiting the enzyme HMG-CoA reductase, which blocks the conversion of HMG-CoA to mevalonate. While this pathway reduces cholesterol synthesis, it also affects the production of other biologically important compounds derived from mevalonate, including coenzyme Q10 (CoQ10).
CoQ10 plays a critical role in mitochondrial energy production, and the heart contains particularly high concentrations of this nutrient. Reduced CoQ10 levels have been observed in people with congestive heart failure. Statin therapy has been associated with reduced CoQ10 levels, which may help explain commonly reported side effects such as muscle pain, exercise intolerance, and weakness. In rare cases, more severe muscle injury can occur. Regulatory agencies have also issued warnings regarding potential liver-related adverse effects.
An article published in The Lancet (1998; 352(Suppl 1):39–41) noted that the prevalence of heart failure increased substantially during the latter part of the 20th century. While this trend coincided with expanded use of cholesterol-lowering therapies, the authors did not establish causation, and multiple factors likely contributed to the rise in heart failure prevalence.